Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
Clinical trial NCT06992440 · RECRUITING
Trial details
- NCT number
- NCT06992440
- Sponsor
- Gustavo A Heresi, MD, MS
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-26
- Primary completion
- 2030-07-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.